Skip to main content

Security report for nucleusnetwork.com

Nucleus Network · Healthcare · N/a

Medium risk. 7 critical or high findings in Security headers, GDPR outside view and 1 other check.

Security score

66/100

Risk levelMedium

0–100, higher is better. How it is calculated

Nucleus Network is a clinical research organization specializing in Phase I clinical trials for global biotechnology and pharmaceutical companies. The website presents a professional and modern digital presence, leveraging advanced JavaScript frameworks and multiple marketing and analytics tools to engage its target audience. However, the absence of WHOIS registration data and lack of visible contact or privacy information on the site introduces trust and compliance concerns. The technical infrastructure is modern and mobile-optimized, but security best practices such as security headers and privacy policies are missing or not evident. Overall, while the business appears legitimate and established in the healthcare sector, the lack of transparency in domain registration and privacy compliance reduces the overall trustworthiness and security posture of the website.

Scanned

NIS2 and GDPR posture

GDPR outside view
35/ 100 · High
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

7 findings rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

  2. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Privacy Policy found

      GDPR requires a clear and accessible privacy policy

      What to do: Add a comprehensive privacy policy page and link to it prominently

    • High

      No Cookie Policy found

      GDPR requires clear information about cookie usage

      What to do: Add a dedicated cookie policy explaining cookie usage and purposes

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

Need hands-on remediation? Email guard@offseq.com

Keep watching nucleusnetwork.com

This scan found 21 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. See sample alerts.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
75
Security headers
30
Email security
77
DNS health
80
Network security
100
GDPR outside view
35
Average
66

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

The company targets global biotechnology and pharmaceutical sectors, offering Phase I clinical trial services. The business model is service-oriented, focusing on clinical research. The website content is relevant and well-structured, indicating a medium-sized enterprise with consistent branding. The extensive use of third-party marketing and tracking tools suggests a focus on lead generation and customer engagement. However, the lack of explicit contact details and privacy compliance documentation may hinder trust from potential clients and partners. No parent or subsidiary relationships are evident from the data.

Security posture

The website employs HTTPS, which is a fundamental security measure. However, it lacks critical security headers such as Content-Security-Policy and X-Frame-Options, which are important to mitigate common web vulnerabilities. The absence of privacy and cookie policies indicates potential compliance gaps with GDPR and other data protection regulations. No incident response or security contact information is provided, which is a risk factor for handling security incidents. The use of multiple third-party scripts increases the attack surface and requires vigilant monitoring. Overall, the security posture is moderate but requires improvements to align with best practices and regulatory requirements.

Recommendations

  1. Implement comprehensive privacy and cookie policies prominently on the website to improve GDPR compliance and user trust.
  2. Add security headers including Content-Security-Policy, X-Frame-Options, X-Content-Type-Options, and Strict-Transport-Security to enhance protection against common web attacks.
  3. Publish clear contact information including security incident response contacts and data protection officer details to improve transparency and compliance.
  4. Review and audit third-party scripts regularly to minimize security risks and ensure data protection.
  5. Obtain and publish WHOIS registration details or ensure domain registration information is accurate and publicly available to enhance domain trustworthiness.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Nucleus Network
Description
We service Global Biotechnology and Pharmaceutical companies from U.S, Europe and Asia and conduct 50-60 Phase I Clinical Trials each year.
Key services
Phase I Clinical Trials, Clinical Research Services
Content quality
good
Branding
consistent

Technology

Stack
Google Analytics, Facebook Pixel, Snapchat Pixel, CrazyEgg, Calendly Widget, Nuxt.js, Google Tag Manager, StackAdapt, Microsoft Clarity, Instabot
Frameworks
Nuxt.js
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
70/100
Good practices seen
  • HTTPS enabled
  • No exposed sensitive data in HTML

Analytics and tracking

Services
Google Analytics, Facebook Pixel, Microsoft Clarity, CrazyEgg, Snapchat Pixel
Tracking level
extensive
Privacy practices
poor

Advertising

Ad networks
StackAdapt, Bing Ads, Reddit Ads
Tracking pixels
Facebook Pixel, Snapchat Pixel, Microsoft Clarity, CrazyEgg
Marketing tools
Calendly, Instabot, Podscribe
Transparency
basic

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
moderate

Key observations

  1. Website is fully accessible with no blocking or WAF challenge.
  2. WHOIS data is missing, which is unusual and reduces domain trust.
  3. No privacy, cookie, or terms of service policies found on the homepage HTML content.
  4. No contact emails or phone numbers explicitly found in the HTML content.
  5. Multiple third-party tracking and marketing scripts are used extensively.
  6. No visible security headers detected in the HTML content.
  7. Website uses modern JavaScript framework Nuxt.js and is mobile optimized.
  8. Content is relevant and professional for clinical trial services.
  9. No explicit security or incident response information is provided.
Technical notes

Notes

The website is built using Nuxt.js, a modern Vue.js framework, indicating a contemporary and scalable technical infrastructure. It integrates multiple analytics and marketing tools such as Google Analytics, Facebook Pixel, Microsoft Clarity, and CrazyEgg, which provide extensive user behavior insights but also increase privacy and security considerations. The site is mobile optimized and has good SEO meta tags, but lacks accessibility enhancements. Performance is moderate, likely influenced by numerous external scripts. No CMS or hosting provider details are evident from the HTML content. The absence of security headers and privacy policies indicates technical debt in security and compliance areas.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with nucleusnetwork.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review nucleusnetwork.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.